Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

Jordan Thorpe,Matthew D. Perry,Osvaldo Contreras,Emily Hurley,George Parker,Richard P. Harvey,Adam P. Hill,Jamie I. Vandenberg,Adam P. Hill and Jamie I. Vandenberg

DOI: https://doi.org/10.1186/s13287-023-03405-5

2023-07-28

Stem Cell Research & Therapy

Abstract:Atrial fibrillation is the most common arrhythmia syndrome and causes significant morbidity and mortality. Current therapeutics, however, have limited efficacy. Notably, many therapeutics shown to be efficacious in animal models have not proved effective in humans. Thus, there is a need for a drug screening platform based on human tissue. The aim of this study was to develop a robust protocol for generating atrial cardiomyocytes from human-induced pluripotent stem cells.

cell biology,medicine, research & experimental,cell & tissue engineering